chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram head abnormal, Confusional state, Diarrhoea, Electrocardiogram abnormal, Fall
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 2/9/21 (013M20A) Moderna Dose 2 3/9/21 (002A21A) COVID Positive 11/4/21  11/4/21: Patient is 72-year-old female with past medical history of Alzheimer dementia, type 2 diabetes mellitus, hypertension, dyslipidemia and obesity. to the emergency room by her daughter for complaint of diarrhea and increased confusion.  Patient has Alzheimer dementia with mild cognitive decline.  Patient was able to engage in meaningful conversation and  give history. History was corroborated by her daughter.  Patient was seen at Hospital ED on 10/27/2021 for complaint of right-sided body weakness, unsteady gait and frequent falls for a week. She had multiple workups including CT head which was negative.  Patient was sent home with an appointment follow-up with her neurologist.  She was also started with aspirin 81 mg p.o. daily. She was seen at her neurologist's office 2 days ago and was presumed to have possible stroke.  Further evaluation for stroke with MRI of the brain and CT angio head/neck was planned by her neurologist and patient was scheduled to have this test done next week.  However, since 4 days ago, patient has been having diarrhea.  Patient reported up to 3-4 loose bowel movements.  No associated abdominal pain, nausea vomiting.  No report of fever chills or rigors.  Stool was brown in color.  No associated blood.  Patient also reported increased weakness. Family members also reported increased confusion.  Since her recent diagnosis for stroke, she has been using a walker.  Family members reported less episodes of fall since she started using walker. No report of chest pain, shortness of breath or palpitations.  No urinary complaints.  Patient denied use of laxatives.  Patient is fully vaccinated for COVID-19. She denied use of tobacco products.  She drinks alcohol occasionally.  Upon evaluation at the emergency room, she was afebrile, hemodynamically stable and maintaining saturation on room air.  Significant lab findings were hypokalemia 3.3 and leukopenia 3.27.  EKG revealed sinus bradycardia without acute ST or T-wave changes.  CT head without contrast was done which showed prominent area of low-density in left parietal lobe suspicious for acute infarct.  11/8/21: Patient is 72-year-old female with history of hypertension, hyperlipidemia, recently diagnosed Alzheimer dementia, and depression who presented with right-sided weakness admitted for CVA workup found to have small multifocal subacute infarcts involving the left parietal lobe.  Started on aspirin, statin, neurology consulted. Patient was complaining of diarrhea, tested positive for COVID-19 with no respiratory involvement.  Was on supportive care with IV fluids.  Worked with physical therapy and did very well and plan to discharge to home today.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Hemiparesis, Hypokalaemia, Leukopenia, Sinus bradycardia
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 2/9/21 (013M20A) Moderna Dose 2 3/9/21 (002A21A) COVID Positive 11/4/21  11/4/21: Patient is 72-year-old female with past medical history of Alzheimer dementia, type 2 diabetes mellitus, hypertension, dyslipidemia and obesity. to the emergency room by her daughter for complaint of diarrhea and increased confusion.  Patient has Alzheimer dementia with mild cognitive decline.  Patient was able to engage in meaningful conversation and  give history. History was corroborated by her daughter.  Patient was seen at Hospital ED on 10/27/2021 for complaint of right-sided body weakness, unsteady gait and frequent falls for a week. She had multiple workups including CT head which was negative.  Patient was sent home with an appointment follow-up with her neurologist.  She was also started with aspirin 81 mg p.o. daily. She was seen at her neurologist's office 2 days ago and was presumed to have possible stroke.  Further evaluation for stroke with MRI of the brain and CT angio head/neck was planned by her neurologist and patient was scheduled to have this test done next week.  However, since 4 days ago, patient has been having diarrhea.  Patient reported up to 3-4 loose bowel movements.  No associated abdominal pain, nausea vomiting.  No report of fever chills or rigors.  Stool was brown in color.  No associated blood.  Patient also reported increased weakness. Family members also reported increased confusion.  Since her recent diagnosis for stroke, she has been using a walker.  Family members reported less episodes of fall since she started using walker. No report of chest pain, shortness of breath or palpitations.  No urinary complaints.  Patient denied use of laxatives.  Patient is fully vaccinated for COVID-19. She denied use of tobacco products.  She drinks alcohol occasionally.  Upon evaluation at the emergency room, she was afebrile, hemodynamically stable and maintaining saturation on room air.  Significant lab findings were hypokalemia 3.3 and leukopenia 3.27.  EKG revealed sinus bradycardia without acute ST or T-wave changes.  CT head without contrast was done which showed prominent area of low-density in left parietal lobe suspicious for acute infarct.  11/8/21: Patient is 72-year-old female with history of hypertension, hyperlipidemia, recently diagnosed Alzheimer dementia, and depression who presented with right-sided weakness admitted for CVA workup found to have small multifocal subacute infarcts involving the left parietal lobe.  Started on aspirin, statin, neurology consulted. Patient was complaining of diarrhea, tested positive for COVID-19 with no respiratory involvement.  Was on supportive care with IV fluids.  Worked with physical therapy and did very well and plan to discharge to home today.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection, Walking aid user, White blood cell count decreased
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 2/9/21 (013M20A) Moderna Dose 2 3/9/21 (002A21A) COVID Positive 11/4/21  11/4/21: Patient is 72-year-old female with past medical history of Alzheimer dementia, type 2 diabetes mellitus, hypertension, dyslipidemia and obesity. to the emergency room by her daughter for complaint of diarrhea and increased confusion.  Patient has Alzheimer dementia with mild cognitive decline.  Patient was able to engage in meaningful conversation and  give history. History was corroborated by her daughter.  Patient was seen at Hospital ED on 10/27/2021 for complaint of right-sided body weakness, unsteady gait and frequent falls for a week. She had multiple workups including CT head which was negative.  Patient was sent home with an appointment follow-up with her neurologist.  She was also started with aspirin 81 mg p.o. daily. She was seen at her neurologist's office 2 days ago and was presumed to have possible stroke.  Further evaluation for stroke with MRI of the brain and CT angio head/neck was planned by her neurologist and patient was scheduled to have this test done next week.  However, since 4 days ago, patient has been having diarrhea.  Patient reported up to 3-4 loose bowel movements.  No associated abdominal pain, nausea vomiting.  No report of fever chills or rigors.  Stool was brown in color.  No associated blood.  Patient also reported increased weakness. Family members also reported increased confusion.  Since her recent diagnosis for stroke, she has been using a walker.  Family members reported less episodes of fall since she started using walker. No report of chest pain, shortness of breath or palpitations.  No urinary complaints.  Patient denied use of laxatives.  Patient is fully vaccinated for COVID-19. She denied use of tobacco products.  She drinks alcohol occasionally.  Upon evaluation at the emergency room, she was afebrile, hemodynamically stable and maintaining saturation on room air.  Significant lab findings were hypokalemia 3.3 and leukopenia 3.27.  EKG revealed sinus bradycardia without acute ST or T-wave changes.  CT head without contrast was done which showed prominent area of low-density in left parietal lobe suspicious for acute infarct.  11/8/21: Patient is 72-year-old female with history of hypertension, hyperlipidemia, recently diagnosed Alzheimer dementia, and depression who presented with right-sided weakness admitted for CVA workup found to have small multifocal subacute infarcts involving the left parietal lobe.  Started on aspirin, statin, neurology consulted. Patient was complaining of diarrhea, tested positive for COVID-19 with no respiratory involvement.  Was on supportive care with IV fluids.  Worked with physical therapy and did very well and plan to discharge to home today.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash erythematous, Rash pruritic, Skin warm
Clinical narrative: This all began on 04/16/2022. I am not sure if it is related but the doctor thought it may have started to wake up something. I went in my hot tub and then took a shower and the rash bright red it looked like a line from my ear to my neck that was in a V shape. it went a little under both breasts and a little under my arm pit. It was itchy, hot and painful. My head was itchy also, so I was using Sarna lotion liberally all over. By Sunday or Monday I was using hydrocortisone cream on my neck because that was the worst. After that the symptoms slowly diminished so each day was a little better. I kept my EpiPen with me, I though I may needed to go to a quick care place, but decided to wait. I got in to see my doctor 04/20/2022. She looked at the rash, however it was much better and I was told stop the hydrocortisone cream and stay out of the hot tub. I have just been taking luke warm showers. Every so often I get a light itchy feeling and I just rub it lightly. It is mostly gone now.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Pyrexia
Clinical narrative: History of esophageal cancer and chronic pain who presents with fevers and SOB. Patient treated with Decadron and Remdesevir
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine given
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Neuralgia
Clinical narrative: Starting the end of February 2022, I thought I had a bug bite. I realized it wasn't a bug bite and called my doctor. They told me I had shingles. I had a pretty bad episode of nerve pain and put on gabapentin. It lasted about 6 weeks and then it resolved for the most part. I still have episodes of nerve pain but I no longer take the gabapentin anymore.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus considerably worse and still worse on 4-22-22
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Anaemia, Blood calcium decreased, Blood potassium decreased, C-reactive protein increased
Clinical narrative: COVID Breakthrough Case  J&J Dose 3/16/21 1805018 COVID Positive 11/3/21  11/7/21: The patient is a 49 year old male from who presented to ED with complaints of shortness of breath. He started feeling ill early last week with fevers, headache, fatigue and body aches. He was tested for Covid-19 on Wednesday with positive results. He did received J&J vaccination. He was treated with a Z-pack with no improvements in his symptoms. His symptoms have progressively gotten worse. He began having nausea and vomiting yesterday. Today he developed severe shortness of breath with activity and at rest. He denies chest pain. He has "chest tightness" when he coughs.  He has a past medical history significant for hypertension.  On arrival to ED the patient was hypoxic on room air at 87%, 2 L supplemental oxygen was applied with improvement in oxygenation saturations to 94%.  Laboratory findings were significant for hypokalemia 3.3.  Hypocalcemia 8.6. Anemia HGB 12.9.  C reactive 13.30.  Chest x-ray showed bilateral lung infiltrates.  Rocephin and doxycycline were initiated in ED.  Dexamethasone given. NS 0.9% 500 mL bolus given.  11/13/21: Patient is a 49yo male who presented and was managed for COVID 19 pneumonia  He completed course of IV remdesivir  He received IV decadron and discharged on 3 days decadron PO to complete 10 day course  He was on Ceftriaxone and Doxycycline for possible underlying bacterial pneumonia  His symptoms improved and he was able wean off oxygen  He had complaints of bruising and soreness in his abdomen but US soft tissue was negative for hematoma  He had O2 walk test and does not require supplemental oxygen upon discharge
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chest discomfort, Contusion
Clinical narrative: COVID Breakthrough Case  J&J Dose 3/16/21 1805018 COVID Positive 11/3/21  11/7/21: The patient is a 49 year old male from who presented to ED with complaints of shortness of breath. He started feeling ill early last week with fevers, headache, fatigue and body aches. He was tested for Covid-19 on Wednesday with positive results. He did received J&J vaccination. He was treated with a Z-pack with no improvements in his symptoms. His symptoms have progressively gotten worse. He began having nausea and vomiting yesterday. Today he developed severe shortness of breath with activity and at rest. He denies chest pain. He has "chest tightness" when he coughs.  He has a past medical history significant for hypertension.  On arrival to ED the patient was hypoxic on room air at 87%, 2 L supplemental oxygen was applied with improvement in oxygenation saturations to 94%.  Laboratory findings were significant for hypokalemia 3.3.  Hypocalcemia 8.6. Anemia HGB 12.9.  C reactive 13.30.  Chest x-ray showed bilateral lung infiltrates.  Rocephin and doxycycline were initiated in ED.  Dexamethasone given. NS 0.9% 500 mL bolus given.  11/13/21: Patient is a 49yo male who presented and was managed for COVID 19 pneumonia  He completed course of IV remdesivir  He received IV decadron and discharged on 3 days decadron PO to complete 10 day course  He was on Ceftriaxone and Doxycycline for possible underlying bacterial pneumonia  His symptoms improved and he was able wean off oxygen  He had complaints of bruising and soreness in his abdomen but US soft tissue was negative for hematoma  He had O2 walk test and does not require supplemental oxygen upon discharge
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Dyspnoea at rest, Dyspnoea exertional, Fatigue
Clinical narrative: COVID Breakthrough Case  J&J Dose 3/16/21 1805018 COVID Positive 11/3/21  11/7/21: The patient is a 49 year old male from who presented to ED with complaints of shortness of breath. He started feeling ill early last week with fevers, headache, fatigue and body aches. He was tested for Covid-19 on Wednesday with positive results. He did received J&J vaccination. He was treated with a Z-pack with no improvements in his symptoms. His symptoms have progressively gotten worse. He began having nausea and vomiting yesterday. Today he developed severe shortness of breath with activity and at rest. He denies chest pain. He has "chest tightness" when he coughs.  He has a past medical history significant for hypertension.  On arrival to ED the patient was hypoxic on room air at 87%, 2 L supplemental oxygen was applied with improvement in oxygenation saturations to 94%.  Laboratory findings were significant for hypokalemia 3.3.  Hypocalcemia 8.6. Anemia HGB 12.9.  C reactive 13.30.  Chest x-ray showed bilateral lung infiltrates.  Rocephin and doxycycline were initiated in ED.  Dexamethasone given. NS 0.9% 500 mL bolus given.  11/13/21: Patient is a 49yo male who presented and was managed for COVID 19 pneumonia  He completed course of IV remdesivir  He received IV decadron and discharged on 3 days decadron PO to complete 10 day course  He was on Ceftriaxone and Doxycycline for possible underlying bacterial pneumonia  His symptoms improved and he was able wean off oxygen  He had complaints of bruising and soreness in his abdomen but US soft tissue was negative for hematoma  He had O2 walk test and does not require supplemental oxygen upon discharge
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Headache, Hypocalcaemia, Hypokalaemia, Hypoxia
Clinical narrative: COVID Breakthrough Case  J&J Dose 3/16/21 1805018 COVID Positive 11/3/21  11/7/21: The patient is a 49 year old male from who presented to ED with complaints of shortness of breath. He started feeling ill early last week with fevers, headache, fatigue and body aches. He was tested for Covid-19 on Wednesday with positive results. He did received J&J vaccination. He was treated with a Z-pack with no improvements in his symptoms. His symptoms have progressively gotten worse. He began having nausea and vomiting yesterday. Today he developed severe shortness of breath with activity and at rest. He denies chest pain. He has "chest tightness" when he coughs.  He has a past medical history significant for hypertension.  On arrival to ED the patient was hypoxic on room air at 87%, 2 L supplemental oxygen was applied with improvement in oxygenation saturations to 94%.  Laboratory findings were significant for hypokalemia 3.3.  Hypocalcemia 8.6. Anemia HGB 12.9.  C reactive 13.30.  Chest x-ray showed bilateral lung infiltrates.  Rocephin and doxycycline were initiated in ED.  Dexamethasone given. NS 0.9% 500 mL bolus given.  11/13/21: Patient is a 49yo male who presented and was managed for COVID 19 pneumonia  He completed course of IV remdesivir  He received IV decadron and discharged on 3 days decadron PO to complete 10 day course  He was on Ceftriaxone and Doxycycline for possible underlying bacterial pneumonia  His symptoms improved and he was able wean off oxygen  He had complaints of bruising and soreness in his abdomen but US soft tissue was negative for hematoma  He had O2 walk test and does not require supplemental oxygen upon discharge
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Lung infiltration, Malaise, Nausea, Pain, Pyrexia
Clinical narrative: COVID Breakthrough Case  J&J Dose 3/16/21 1805018 COVID Positive 11/3/21  11/7/21: The patient is a 49 year old male from who presented to ED with complaints of shortness of breath. He started feeling ill early last week with fevers, headache, fatigue and body aches. He was tested for Covid-19 on Wednesday with positive results. He did received J&J vaccination. He was treated with a Z-pack with no improvements in his symptoms. His symptoms have progressively gotten worse. He began having nausea and vomiting yesterday. Today he developed severe shortness of breath with activity and at rest. He denies chest pain. He has "chest tightness" when he coughs.  He has a past medical history significant for hypertension.  On arrival to ED the patient was hypoxic on room air at 87%, 2 L supplemental oxygen was applied with improvement in oxygenation saturations to 94%.  Laboratory findings were significant for hypokalemia 3.3.  Hypocalcemia 8.6. Anemia HGB 12.9.  C reactive 13.30.  Chest x-ray showed bilateral lung infiltrates.  Rocephin and doxycycline were initiated in ED.  Dexamethasone given. NS 0.9% 500 mL bolus given.  11/13/21: Patient is a 49yo male who presented and was managed for COVID 19 pneumonia  He completed course of IV remdesivir  He received IV decadron and discharged on 3 days decadron PO to complete 10 day course  He was on Ceftriaxone and Doxycycline for possible underlying bacterial pneumonia  His symptoms improved and he was able wean off oxygen  He had complaints of bruising and soreness in his abdomen but US soft tissue was negative for hematoma  He had O2 walk test and does not require supplemental oxygen upon discharge
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Ultrasound scan normal, Vaccine breakthrough infection, Vomiting
Clinical narrative: COVID Breakthrough Case  J&J Dose 3/16/21 1805018 COVID Positive 11/3/21  11/7/21: The patient is a 49 year old male from who presented to ED with complaints of shortness of breath. He started feeling ill early last week with fevers, headache, fatigue and body aches. He was tested for Covid-19 on Wednesday with positive results. He did received J&J vaccination. He was treated with a Z-pack with no improvements in his symptoms. His symptoms have progressively gotten worse. He began having nausea and vomiting yesterday. Today he developed severe shortness of breath with activity and at rest. He denies chest pain. He has "chest tightness" when he coughs.  He has a past medical history significant for hypertension.  On arrival to ED the patient was hypoxic on room air at 87%, 2 L supplemental oxygen was applied with improvement in oxygenation saturations to 94%.  Laboratory findings were significant for hypokalemia 3.3.  Hypocalcemia 8.6. Anemia HGB 12.9.  C reactive 13.30.  Chest x-ray showed bilateral lung infiltrates.  Rocephin and doxycycline were initiated in ED.  Dexamethasone given. NS 0.9% 500 mL bolus given.  11/13/21: Patient is a 49yo male who presented and was managed for COVID 19 pneumonia  He completed course of IV remdesivir  He received IV decadron and discharged on 3 days decadron PO to complete 10 day course  He was on Ceftriaxone and Doxycycline for possible underlying bacterial pneumonia  His symptoms improved and he was able wean off oxygen  He had complaints of bruising and soreness in his abdomen but US soft tissue was negative for hematoma  He had O2 walk test and does not require supplemental oxygen upon discharge
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine given
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac monitoring normal, Discomfort, Electrocardiogram, Fatigue, Hypoaesthesia
Clinical narrative: Couple of hours after vaccine, injection site pain, flu like symptoms, hurt all over, fatigued, nauseated.  Symptoms lasted for one night after vaccine.  I don't remember if I took anything for discomfort. In January, I felt nauseated at work, heart racing,  feeling numb (arm, tongue, hands), did not feel well, hands starting cramping. Went to Urgent Care and they called for ambulance.  I feel like I am having panic attacks. The doctor gave me breathing exercises to help me calm down.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Influenza like illness, Injection site pain, Malaise, Muscle spasms
Clinical narrative: Couple of hours after vaccine, injection site pain, flu like symptoms, hurt all over, fatigued, nauseated.  Symptoms lasted for one night after vaccine.  I don't remember if I took anything for discomfort. In January, I felt nauseated at work, heart racing,  feeling numb (arm, tongue, hands), did not feel well, hands starting cramping. Went to Urgent Care and they called for ambulance.  I feel like I am having panic attacks. The doctor gave me breathing exercises to help me calm down.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Palpitations, Panic attack
Clinical narrative: Couple of hours after vaccine, injection site pain, flu like symptoms, hurt all over, fatigued, nauseated.  Symptoms lasted for one night after vaccine.  I don't remember if I took anything for discomfort. In January, I felt nauseated at work, heart racing,  feeling numb (arm, tongue, hands), did not feel well, hands starting cramping. Went to Urgent Care and they called for ambulance.  I feel like I am having panic attacks. The doctor gave me breathing exercises to help me calm down.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine given
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anxiety, Condition aggravated, Feelings of worthlessness, Headache, Hormone level abnormal
Clinical narrative: Discomfort relating to every menstrual cycle, inability to predict hormonal spikes & drops throughout the month resulting in suicidal ideation, migraines, anxiety I am seeking hormonal contraception to help level out my hormones; I take Excedrin migraine pill or ibuprofen for pain.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Interchange of vaccine products, Intermenstrual bleeding, Menstrual discomfort, Menstruation irregular, Migraine
Clinical narrative: Discomfort relating to every menstrual cycle, inability to predict hormonal spikes & drops throughout the month resulting in suicidal ideation, migraines, anxiety I am seeking hormonal contraception to help level out my hormones; I take Excedrin migraine pill or ibuprofen for pain.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Polymenorrhoea, Premenstrual syndrome, Suicidal ideation
Clinical narrative: Discomfort relating to every menstrual cycle, inability to predict hormonal spikes & drops throughout the month resulting in suicidal ideation, migraines, anxiety I am seeking hormonal contraception to help level out my hormones; I take Excedrin migraine pill or ibuprofen for pain.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine given
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Feeling abnormal, Immunisation reaction, Lethargy
Clinical narrative: I went to the pharmacy had my covid shot. I waited my 15 minutes and went home. I was feeling well covid arm but it went away. Months later I got Covid. I was out of work for about 2 weeks. I notice it at worked I left home early. I was feeling bad at work. I had a fever for the first couple of days, I was very tired and lethargic. I did have after effect. I had Osteopenia in my neck.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Osteopenia, Pyrexia, SARS-CoV-2 test
Clinical narrative: I went to the pharmacy had my covid shot. I waited my 15 minutes and went home. I was feeling well covid arm but it went away. Months later I got Covid. I was out of work for about 2 weeks. I notice it at worked I left home early. I was feeling bad at work. I had a fever for the first couple of days, I was very tired and lethargic. I did have after effect. I had Osteopenia in my neck.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine given
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Aspartate aminotransferase increased, Asthenia, Autoimmune disorder
Clinical narrative: COVID Breakthrough Case Pfizer Dose 1 4/22/21 (ER8731) Pfizer Dose 2 5/14/21 (EW0168) COVID Positive 11/15/21  11/21/21: Patient is a 59 year old female who presented to ED via EMS with complaints of shortness of breath that began yesterday. On arrival of EMS the patient was saturating on room air at 66%, DuoNeb was administered, she was placed on 15 L non-rebreather with improvement in oxygen saturation to 96%. Pt began having headaches and fatigue one week ago. Two days later she developed chills, decreased appetite, nausea and a cough. She was tested at Urgent Care and notified two days later, on Wednesday that she was positive. Yesterday she started becoming short of breath and "hot." She became very weak to the point where her husband had to walk her to the restroom. She denies any abdominal pain, vomiting or diarrhea. Denies chest pain. She is fully vaccinated against Covid-19. She denies any history of asthma or tobacco use. She has a past medical history of anxiety/depression and neuromyelitis optica. She is followed by Dr. with neurology for her autoimmune disease, she received her first Rituxan infusion back in July.  On arrival to ED the patient febrile 101, tachycardic 123 and hypoxic on 15 L non-rebreather at 86%.  She was placed on high-flow nasal cannula 40L with 70 FiO2.  Laboratory findings were significant for hyponatremia 133. Transaminitis AST 54. D-dimer 1.63.  C reactive 24.0. Chest x-ray showed extensive bilateral pneumonia.  CT chest negative for PE.  Extensive bilateral patchy consolidated pneumonia.  Patient received ceftriaxone and Decadron in ED. She received NS 1 L in ED.  12/1/21: Acute hypoxic respiratory failure status post intubation on 11/23/2021  Severe bilateral COVID-19 pneumonia, vaccinated status  Superimposed bacterial pneumonia  Hypotension concerning for septic and hemorrhagic shock requiring multiple vasopressors  Acute blood loss anemia secondary to GI bleeding status post PRBC transfusion Upper gastrointestinal bleeding status post endoscopy on 11/29/2021  Acute kidney injury likely due to hypoperfusion Severely elevated liver function enzymes likely due to shock liver Elevated serum inflammatory markers secondary to infection  Hyponatremia  Morbid obesity  Anxiety/depression  Neuromyelitis optica, chronic. Patient passed away on 12/01/2021 at 14:07  Patient was made DNR status and was started on comfort measures per family's request
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood loss anaemia, Blood sodium decreased, C-reactive protein increased, COVID-19, COVID-19 pneumonia
Clinical narrative: COVID Breakthrough Case Pfizer Dose 1 4/22/21 (ER8731) Pfizer Dose 2 5/14/21 (EW0168) COVID Positive 11/15/21  11/21/21: Patient is a 59 year old female who presented to ED via EMS with complaints of shortness of breath that began yesterday. On arrival of EMS the patient was saturating on room air at 66%, DuoNeb was administered, she was placed on 15 L non-rebreather with improvement in oxygen saturation to 96%. Pt began having headaches and fatigue one week ago. Two days later she developed chills, decreased appetite, nausea and a cough. She was tested at Urgent Care and notified two days later, on Wednesday that she was positive. Yesterday she started becoming short of breath and "hot." She became very weak to the point where her husband had to walk her to the restroom. She denies any abdominal pain, vomiting or diarrhea. Denies chest pain. She is fully vaccinated against Covid-19. She denies any history of asthma or tobacco use. She has a past medical history of anxiety/depression and neuromyelitis optica. She is followed by Dr. with neurology for her autoimmune disease, she received her first Rituxan infusion back in July.  On arrival to ED the patient febrile 101, tachycardic 123 and hypoxic on 15 L non-rebreather at 86%.  She was placed on high-flow nasal cannula 40L with 70 FiO2.  Laboratory findings were significant for hyponatremia 133. Transaminitis AST 54. D-dimer 1.63.  C reactive 24.0. Chest x-ray showed extensive bilateral pneumonia.  CT chest negative for PE.  Extensive bilateral patchy consolidated pneumonia.  Patient received ceftriaxone and Decadron in ED. She received NS 1 L in ED.  12/1/21: Acute hypoxic respiratory failure status post intubation on 11/23/2021  Severe bilateral COVID-19 pneumonia, vaccinated status  Superimposed bacterial pneumonia  Hypotension concerning for septic and hemorrhagic shock requiring multiple vasopressors  Acute blood loss anemia secondary to GI bleeding status post PRBC transfusion Upper gastrointestinal bleeding status post endoscopy on 11/29/2021  Acute kidney injury likely due to hypoperfusion Severely elevated liver function enzymes likely due to shock liver Elevated serum inflammatory markers secondary to infection  Hyponatremia  Morbid obesity  Anxiety/depression  Neuromyelitis optica, chronic. Patient passed away on 12/01/2021 at 14:07  Patient was made DNR status and was started on comfort measures per family's request
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Chills, Computerised tomogram thorax abnormal, Condition aggravated, Cough
Clinical narrative: COVID Breakthrough Case Pfizer Dose 1 4/22/21 (ER8731) Pfizer Dose 2 5/14/21 (EW0168) COVID Positive 11/15/21  11/21/21: Patient is a 59 year old female who presented to ED via EMS with complaints of shortness of breath that began yesterday. On arrival of EMS the patient was saturating on room air at 66%, DuoNeb was administered, she was placed on 15 L non-rebreather with improvement in oxygen saturation to 96%. Pt began having headaches and fatigue one week ago. Two days later she developed chills, decreased appetite, nausea and a cough. She was tested at Urgent Care and notified two days later, on Wednesday that she was positive. Yesterday she started becoming short of breath and "hot." She became very weak to the point where her husband had to walk her to the restroom. She denies any abdominal pain, vomiting or diarrhea. Denies chest pain. She is fully vaccinated against Covid-19. She denies any history of asthma or tobacco use. She has a past medical history of anxiety/depression and neuromyelitis optica. She is followed by Dr. with neurology for her autoimmune disease, she received her first Rituxan infusion back in July.  On arrival to ED the patient febrile 101, tachycardic 123 and hypoxic on 15 L non-rebreather at 86%.  She was placed on high-flow nasal cannula 40L with 70 FiO2.  Laboratory findings were significant for hyponatremia 133. Transaminitis AST 54. D-dimer 1.63.  C reactive 24.0. Chest x-ray showed extensive bilateral pneumonia.  CT chest negative for PE.  Extensive bilateral patchy consolidated pneumonia.  Patient received ceftriaxone and Decadron in ED. She received NS 1 L in ED.  12/1/21: Acute hypoxic respiratory failure status post intubation on 11/23/2021  Severe bilateral COVID-19 pneumonia, vaccinated status  Superimposed bacterial pneumonia  Hypotension concerning for septic and hemorrhagic shock requiring multiple vasopressors  Acute blood loss anemia secondary to GI bleeding status post PRBC transfusion Upper gastrointestinal bleeding status post endoscopy on 11/29/2021  Acute kidney injury likely due to hypoperfusion Severely elevated liver function enzymes likely due to shock liver Elevated serum inflammatory markers secondary to infection  Hyponatremia  Morbid obesity  Anxiety/depression  Neuromyelitis optica, chronic. Patient passed away on 12/01/2021 at 14:07  Patient was made DNR status and was started on comfort measures per family's request
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Decreased appetite, Depression, Dyspnoea, Endoscopy
Clinical narrative: COVID Breakthrough Case Pfizer Dose 1 4/22/21 (ER8731) Pfizer Dose 2 5/14/21 (EW0168) COVID Positive 11/15/21  11/21/21: Patient is a 59 year old female who presented to ED via EMS with complaints of shortness of breath that began yesterday. On arrival of EMS the patient was saturating on room air at 66%, DuoNeb was administered, she was placed on 15 L non-rebreather with improvement in oxygen saturation to 96%. Pt began having headaches and fatigue one week ago. Two days later she developed chills, decreased appetite, nausea and a cough. She was tested at Urgent Care and notified two days later, on Wednesday that she was positive. Yesterday she started becoming short of breath and "hot." She became very weak to the point where her husband had to walk her to the restroom. She denies any abdominal pain, vomiting or diarrhea. Denies chest pain. She is fully vaccinated against Covid-19. She denies any history of asthma or tobacco use. She has a past medical history of anxiety/depression and neuromyelitis optica. She is followed by Dr. with neurology for her autoimmune disease, she received her first Rituxan infusion back in July.  On arrival to ED the patient febrile 101, tachycardic 123 and hypoxic on 15 L non-rebreather at 86%.  She was placed on high-flow nasal cannula 40L with 70 FiO2.  Laboratory findings were significant for hyponatremia 133. Transaminitis AST 54. D-dimer 1.63.  C reactive 24.0. Chest x-ray showed extensive bilateral pneumonia.  CT chest negative for PE.  Extensive bilateral patchy consolidated pneumonia.  Patient received ceftriaxone and Decadron in ED. She received NS 1 L in ED.  12/1/21: Acute hypoxic respiratory failure status post intubation on 11/23/2021  Severe bilateral COVID-19 pneumonia, vaccinated status  Superimposed bacterial pneumonia  Hypotension concerning for septic and hemorrhagic shock requiring multiple vasopressors  Acute blood loss anemia secondary to GI bleeding status post PRBC transfusion Upper gastrointestinal bleeding status post endoscopy on 11/29/2021  Acute kidney injury likely due to hypoperfusion Severely elevated liver function enzymes likely due to shock liver Elevated serum inflammatory markers secondary to infection  Hyponatremia  Morbid obesity  Anxiety/depression  Neuromyelitis optica, chronic. Patient passed away on 12/01/2021 at 14:07  Patient was made DNR status and was started on comfort measures per family's request
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Endotracheal intubation, Fatigue, Feeling hot, Fibrin D dimer, Gait disturbance
Clinical narrative: COVID Breakthrough Case Pfizer Dose 1 4/22/21 (ER8731) Pfizer Dose 2 5/14/21 (EW0168) COVID Positive 11/15/21  11/21/21: Patient is a 59 year old female who presented to ED via EMS with complaints of shortness of breath that began yesterday. On arrival of EMS the patient was saturating on room air at 66%, DuoNeb was administered, she was placed on 15 L non-rebreather with improvement in oxygen saturation to 96%. Pt began having headaches and fatigue one week ago. Two days later she developed chills, decreased appetite, nausea and a cough. She was tested at Urgent Care and notified two days later, on Wednesday that she was positive. Yesterday she started becoming short of breath and "hot." She became very weak to the point where her husband had to walk her to the restroom. She denies any abdominal pain, vomiting or diarrhea. Denies chest pain. She is fully vaccinated against Covid-19. She denies any history of asthma or tobacco use. She has a past medical history of anxiety/depression and neuromyelitis optica. She is followed by Dr. with neurology for her autoimmune disease, she received her first Rituxan infusion back in July.  On arrival to ED the patient febrile 101, tachycardic 123 and hypoxic on 15 L non-rebreather at 86%.  She was placed on high-flow nasal cannula 40L with 70 FiO2.  Laboratory findings were significant for hyponatremia 133. Transaminitis AST 54. D-dimer 1.63.  C reactive 24.0. Chest x-ray showed extensive bilateral pneumonia.  CT chest negative for PE.  Extensive bilateral patchy consolidated pneumonia.  Patient received ceftriaxone and Decadron in ED. She received NS 1 L in ED.  12/1/21: Acute hypoxic respiratory failure status post intubation on 11/23/2021  Severe bilateral COVID-19 pneumonia, vaccinated status  Superimposed bacterial pneumonia  Hypotension concerning for septic and hemorrhagic shock requiring multiple vasopressors  Acute blood loss anemia secondary to GI bleeding status post PRBC transfusion Upper gastrointestinal bleeding status post endoscopy on 11/29/2021  Acute kidney injury likely due to hypoperfusion Severely elevated liver function enzymes likely due to shock liver Elevated serum inflammatory markers secondary to infection  Hyponatremia  Morbid obesity  Anxiety/depression  Neuromyelitis optica, chronic. Patient passed away on 12/01/2021 at 14:07  Patient was made DNR status and was started on comfort measures per family's request
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrointestinal haemorrhage, Headache, Hepatic enzyme increased, Hypertransaminasaemia, Hyponatraemia
Clinical narrative: COVID Breakthrough Case Pfizer Dose 1 4/22/21 (ER8731) Pfizer Dose 2 5/14/21 (EW0168) COVID Positive 11/15/21  11/21/21: Patient is a 59 year old female who presented to ED via EMS with complaints of shortness of breath that began yesterday. On arrival of EMS the patient was saturating on room air at 66%, DuoNeb was administered, she was placed on 15 L non-rebreather with improvement in oxygen saturation to 96%. Pt began having headaches and fatigue one week ago. Two days later she developed chills, decreased appetite, nausea and a cough. She was tested at Urgent Care and notified two days later, on Wednesday that she was positive. Yesterday she started becoming short of breath and "hot." She became very weak to the point where her husband had to walk her to the restroom. She denies any abdominal pain, vomiting or diarrhea. Denies chest pain. She is fully vaccinated against Covid-19. She denies any history of asthma or tobacco use. She has a past medical history of anxiety/depression and neuromyelitis optica. She is followed by Dr. with neurology for her autoimmune disease, she received her first Rituxan infusion back in July.  On arrival to ED the patient febrile 101, tachycardic 123 and hypoxic on 15 L non-rebreather at 86%.  She was placed on high-flow nasal cannula 40L with 70 FiO2.  Laboratory findings were significant for hyponatremia 133. Transaminitis AST 54. D-dimer 1.63.  C reactive 24.0. Chest x-ray showed extensive bilateral pneumonia.  CT chest negative for PE.  Extensive bilateral patchy consolidated pneumonia.  Patient received ceftriaxone and Decadron in ED. She received NS 1 L in ED.  12/1/21: Acute hypoxic respiratory failure status post intubation on 11/23/2021  Severe bilateral COVID-19 pneumonia, vaccinated status  Superimposed bacterial pneumonia  Hypotension concerning for septic and hemorrhagic shock requiring multiple vasopressors  Acute blood loss anemia secondary to GI bleeding status post PRBC transfusion Upper gastrointestinal bleeding status post endoscopy on 11/29/2021  Acute kidney injury likely due to hypoperfusion Severely elevated liver function enzymes likely due to shock liver Elevated serum inflammatory markers secondary to infection  Hyponatremia  Morbid obesity  Anxiety/depression  Neuromyelitis optica, chronic. Patient passed away on 12/01/2021 at 14:07  Patient was made DNR status and was started on comfort measures per family's request
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoperfusion, Hypotension, Hypoxia, Infection, Inflammatory marker increased
Clinical narrative: COVID Breakthrough Case Pfizer Dose 1 4/22/21 (ER8731) Pfizer Dose 2 5/14/21 (EW0168) COVID Positive 11/15/21  11/21/21: Patient is a 59 year old female who presented to ED via EMS with complaints of shortness of breath that began yesterday. On arrival of EMS the patient was saturating on room air at 66%, DuoNeb was administered, she was placed on 15 L non-rebreather with improvement in oxygen saturation to 96%. Pt began having headaches and fatigue one week ago. Two days later she developed chills, decreased appetite, nausea and a cough. She was tested at Urgent Care and notified two days later, on Wednesday that she was positive. Yesterday she started becoming short of breath and "hot." She became very weak to the point where her husband had to walk her to the restroom. She denies any abdominal pain, vomiting or diarrhea. Denies chest pain. She is fully vaccinated against Covid-19. She denies any history of asthma or tobacco use. She has a past medical history of anxiety/depression and neuromyelitis optica. She is followed by Dr. with neurology for her autoimmune disease, she received her first Rituxan infusion back in July.  On arrival to ED the patient febrile 101, tachycardic 123 and hypoxic on 15 L non-rebreather at 86%.  She was placed on high-flow nasal cannula 40L with 70 FiO2.  Laboratory findings were significant for hyponatremia 133. Transaminitis AST 54. D-dimer 1.63.  C reactive 24.0. Chest x-ray showed extensive bilateral pneumonia.  CT chest negative for PE.  Extensive bilateral patchy consolidated pneumonia.  Patient received ceftriaxone and Decadron in ED. She received NS 1 L in ED.  12/1/21: Acute hypoxic respiratory failure status post intubation on 11/23/2021  Severe bilateral COVID-19 pneumonia, vaccinated status  Superimposed bacterial pneumonia  Hypotension concerning for septic and hemorrhagic shock requiring multiple vasopressors  Acute blood loss anemia secondary to GI bleeding status post PRBC transfusion Upper gastrointestinal bleeding status post endoscopy on 11/29/2021  Acute kidney injury likely due to hypoperfusion Severely elevated liver function enzymes likely due to shock liver Elevated serum inflammatory markers secondary to infection  Hyponatremia  Morbid obesity  Anxiety/depression  Neuromyelitis optica, chronic. Patient passed away on 12/01/2021 at 14:07  Patient was made DNR status and was started on comfort measures per family's request
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Ischaemic hepatitis, Lung consolidation, Nausea, Neuromyelitis optica spectrum disorder, Obesity
Clinical narrative: COVID Breakthrough Case Pfizer Dose 1 4/22/21 (ER8731) Pfizer Dose 2 5/14/21 (EW0168) COVID Positive 11/15/21  11/21/21: Patient is a 59 year old female who presented to ED via EMS with complaints of shortness of breath that began yesterday. On arrival of EMS the patient was saturating on room air at 66%, DuoNeb was administered, she was placed on 15 L non-rebreather with improvement in oxygen saturation to 96%. Pt began having headaches and fatigue one week ago. Two days later she developed chills, decreased appetite, nausea and a cough. She was tested at Urgent Care and notified two days later, on Wednesday that she was positive. Yesterday she started becoming short of breath and "hot." She became very weak to the point where her husband had to walk her to the restroom. She denies any abdominal pain, vomiting or diarrhea. Denies chest pain. She is fully vaccinated against Covid-19. She denies any history of asthma or tobacco use. She has a past medical history of anxiety/depression and neuromyelitis optica. She is followed by Dr. with neurology for her autoimmune disease, she received her first Rituxan infusion back in July.  On arrival to ED the patient febrile 101, tachycardic 123 and hypoxic on 15 L non-rebreather at 86%.  She was placed on high-flow nasal cannula 40L with 70 FiO2.  Laboratory findings were significant for hyponatremia 133. Transaminitis AST 54. D-dimer 1.63.  C reactive 24.0. Chest x-ray showed extensive bilateral pneumonia.  CT chest negative for PE.  Extensive bilateral patchy consolidated pneumonia.  Patient received ceftriaxone and Decadron in ED. She received NS 1 L in ED.  12/1/21: Acute hypoxic respiratory failure status post intubation on 11/23/2021  Severe bilateral COVID-19 pneumonia, vaccinated status  Superimposed bacterial pneumonia  Hypotension concerning for septic and hemorrhagic shock requiring multiple vasopressors  Acute blood loss anemia secondary to GI bleeding status post PRBC transfusion Upper gastrointestinal bleeding status post endoscopy on 11/29/2021  Acute kidney injury likely due to hypoperfusion Severely elevated liver function enzymes likely due to shock liver Elevated serum inflammatory markers secondary to infection  Hyponatremia  Morbid obesity  Anxiety/depression  Neuromyelitis optica, chronic. Patient passed away on 12/01/2021 at 14:07  Patient was made DNR status and was started on comfort measures per family's request